Luca Guerra

11PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Veterinary epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Jun 26, 2026
PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensus.

|Oct 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials.

Simonetta Viviani, Chiara Pavoni, Sally F Barrington

|Oct 09, 2025
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT.

Lavinia Monaco, Cinzia Crivellaro, Elisabetta De Bernardi

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

|May 25, 2024
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.

Luca Guerra, Stephane Chauvie, Federico Fallanca

Pageof 2

Frequent Collaborators

3 joint publications

Diego Luigi Cortinovis

3 joint publications

Stephane Chauvie

2 joint publications

Domenico Albano

2 joint publications

Lavinia Monaco